Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia

Seattle, Washington 98104

0 studies enrolling now · 5 studies all time

What they study most

Hemophilia A

Studies at this site

• A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors — Completed
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors — Completed
• A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors — Completed
• An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors — APPROVED_FOR_MARKETING
• A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment — Completed